GRI Bio (GRI) Competitors $0.70 -0.03 (-3.51%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends GRI vs. NAII, DRRX, CDIO, ATHE, LVTX, GDTC, EQ, ENLV, LPCN, and MRKRShould you be buying GRI Bio stock or one of its competitors? The main competitors of GRI Bio include Natural Alternatives International (NAII), DURECT (DRRX), Cardio Diagnostics (CDIO), Alterity Therapeutics (ATHE), LAVA Therapeutics (LVTX), CytoMed Therapeutics (GDTC), Equillium (EQ), Enlivex Therapeutics (ENLV), Lipocine (LPCN), and Marker Therapeutics (MRKR). These companies are all part of the "pharmaceutical products" industry. GRI Bio vs. Natural Alternatives International DURECT Cardio Diagnostics Alterity Therapeutics LAVA Therapeutics CytoMed Therapeutics Equillium Enlivex Therapeutics Lipocine Marker Therapeutics Natural Alternatives International (NASDAQ:NAII) and GRI Bio (NASDAQ:GRI) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, profitability, community ranking, analyst recommendations, valuation, risk, dividends, media sentiment and institutional ownership. Does the MarketBeat Community favor NAII or GRI? Natural Alternatives International received 259 more outperform votes than GRI Bio when rated by MarketBeat users. However, 100.00% of users gave GRI Bio an outperform vote while only 75.94% of users gave Natural Alternatives International an outperform vote. CompanyUnderperformOutperformNatural Alternatives InternationalOutperform Votes26275.94% Underperform Votes8324.06% GRI BioOutperform Votes3100.00% Underperform VotesNo Votes Which has more risk and volatility, NAII or GRI? Natural Alternatives International has a beta of 0.61, meaning that its stock price is 39% less volatile than the S&P 500. Comparatively, GRI Bio has a beta of -2.14, meaning that its stock price is 314% less volatile than the S&P 500. Do analysts rate NAII or GRI? GRI Bio has a consensus target price of $11.50, indicating a potential upside of 1,554.68%. Given GRI Bio's stronger consensus rating and higher probable upside, analysts plainly believe GRI Bio is more favorable than Natural Alternatives International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Natural Alternatives International 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00GRI Bio 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is NAII or GRI more profitable? GRI Bio has a net margin of 0.00% compared to Natural Alternatives International's net margin of -7.53%. Natural Alternatives International's return on equity of -10.23% beat GRI Bio's return on equity.Company Net Margins Return on Equity Return on Assets Natural Alternatives International-7.53% -10.23% -5.38% GRI Bio N/A -289.05%-165.01% Do institutionals & insiders have more ownership in NAII or GRI? 32.4% of Natural Alternatives International shares are held by institutional investors. Comparatively, 34.0% of GRI Bio shares are held by institutional investors. 20.9% of Natural Alternatives International shares are held by insiders. Comparatively, 0.3% of GRI Bio shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has stronger earnings & valuation, NAII or GRI? Natural Alternatives International has higher revenue and earnings than GRI Bio. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNatural Alternatives International$113.80M0.23-$7.22M-$1.44-2.92GRI BioN/AN/A-$13.04MN/AN/A Does the media refer more to NAII or GRI? In the previous week, Natural Alternatives International's average media sentiment score of 0.80 beat GRI Bio's score of 0.00 indicating that Natural Alternatives International is being referred to more favorably in the media. Company Overall Sentiment Natural Alternatives International Positive GRI Bio Neutral SummaryNatural Alternatives International beats GRI Bio on 8 of the 14 factors compared between the two stocks. Get GRI Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for GRI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GRI vs. The Competition Export to ExcelMetricGRI BioPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$6.21M$6.58B$5.40B$9.13BDividend YieldN/A2.96%5.37%4.00%P/E RatioN/A9.9688.9717.53Price / SalesN/A335.131,285.7980.48Price / CashN/A22.6336.6032.90Price / Book0.135.084.964.69Net Income-$13.04M$154.90M$117.96M$224.57M7 Day Performance-7.21%2.57%2.58%3.33%1 Month Performance-6.08%1.49%3.53%5.33%1 Year Performance-97.19%5.46%27.05%22.98% GRI Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GRIGRI Bio2.7789 of 5 stars$0.70-3.5%$11.50+1,554.7%-97.1%$6.21MN/A0.001Positive NewsNAIINatural Alternatives International1.7177 of 5 stars$4.20-0.2%N/A-33.2%$26.04M$112.98M-2.92290Analyst ForecastPositive NewsDRRXDURECT4.0675 of 5 stars$0.83+7.0%$5.00+506.1%+16.1%$25.61M$8.59M-1.3580Positive NewsCDIOCardio Diagnostics2.5256 of 5 stars$0.63-6.4%$2.00+218.5%-76.1%$25.40M$35,688.000.007Gap DownATHEAlterity Therapeutics2.1691 of 5 stars$3.45+3.3%$6.00+73.9%+83.9%$25.20MN/A0.0010Short Interest ↑LVTXLAVA Therapeutics3.1422 of 5 stars$0.99+1.5%$3.33+236.7%-40.9%$25.10M$7.35M-0.9660Positive NewsGDTCCytoMed Therapeutics1.6798 of 5 stars$2.26-18.1%$5.00+121.2%-39.0%$24.72MN/A0.00N/APositive NewsGap UpEQEquillium2.2597 of 5 stars$0.70-0.8%$5.00+619.3%-22.3%$24.63M$45.91M-4.9640News CoverageENLVEnlivex Therapeutics3.6404 of 5 stars$1.15+0.4%$9.50+726.1%-58.8%$24.62MN/A-1.1770Positive NewsLPCNLipocine2.6261 of 5 stars$4.59-6.1%$10.00+117.9%+15.9%$24.55M$7.92M-6.0410News CoverageMRKRMarker Therapeutics4.1096 of 5 stars$2.74-3.2%$19.00+593.4%-43.1%$24.45M$3.31M0.0060News CoverageGap Up Related Companies and Tools Related Companies NAII Alternatives DRRX Alternatives CDIO Alternatives ATHE Alternatives LVTX Alternatives GDTC Alternatives EQ Alternatives ENLV Alternatives LPCN Alternatives MRKR Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:GRI) was last updated on 1/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredThis coin could surge during Trump’s first week in office.Juan has never had a losing trade on Bitcoin. And he booked gains of 312% on Chainlink … Now, he says one v...Weiss Ratings | SponsoredElon’s New AI Firm REVEALEDNvidia’s AI chip … the H100 … has been the holy grail of artificial intelligence… Until now. Because Elo...Paradigm Press | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GRI Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share GRI Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
